OUR COMMITMENT
FOR PATIENTS, CAREGIVERS, LOVED ONES, ADVOCATES & HEALTHCARE SPECIALISTS
The people living with, supporting and treating those with neurological conditions are at the center of what we do. We are grateful for the opportunity to have relationships, partnerships and education that has come from working closely with the community globally, from patients and families, to advocacy leaders and healthcare providers. Your contributions and feedback are crucial to the success in finding safe and effective treatments for a wide range of neurological conditions. We hear you and are working diligently towards our goal of developing novel, transformative medicines.
Thank you for allowing us to be a part of the community.
About the PACIFIC Study
The PACIFIC Study is a Phase 1b/2a clinical trial evaluating participants with Developmental and Epileptic Encephalopathies (DEEs). The primary objectives of the study are to assess the safety and tolerability of LP352. The PACIFIC Study will also evaluate change in seizure frequency over the treatment period. The study enrolled 52 participants with a variety of treatment resistant seizures that fall into the category of DEE across approximately 30 study sites in the United States and Australia. The PACIFIC Study data are expected to inform the design and characteristics of the planned Phase 3 program for LP352. Participants who complete the PACIFIC Study are eligible to roll over into the ongoing open-label extension (OLE) trial should they choose to do so. The OLE is a Phase 2 multicenter, open-label, multiple-dose, long-term extension clinical trial designed to evaluate long-term safety of LP352 in participants with DEEs who have completed the PACIFIC Study.
Learn more about PACIFIC here.
At Longboard, we are committed to providing personalized support services throughout a patient and caregiver’s journey. Through this commitment, we have developed Longboard Assist, our internally developed program which includes patient service and support across several key areas including disease and education treatment and assistance in clinical study participation including telehealth and home health services, transportation, lodging, etc.
Reach Out
For questions or comments please feel free to reach out to us directly at [email protected].
For questions or comments please feel free to reach out to us directly through email.
Advocacy & Research Partnerships
We have engaged multiple advocacy and research groups across the DEE landscape in order to optimize the design of the PACIFIC study, increase study awareness in the community, and to enrich our understanding of the evolving DEE environment.
